Note: Ingredients listed on restricted chemical lists
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
N/A
EC/CAS
532-32-1
Name of the chemical
Benzoic acid and its sodium salt
Concentration
N/A
General Information
Revision date
2022-03-04
Product name
AUGMENTIN 7:1 ORAL SUSPENSION POWDER IN BOTTLE
Product Synonyms
AUGMENTIN DUO 200/28.5 MG/5 ML * AUGMENTIN DUO 400/57 MG/5 ML * AUGMENTIN 200
1.2.2. Uses advised against
No other uses are advised
Emergency telephone
+1-612-221-3999, Ext 221
Icons in SDS
Company Information
company name
GlaxoSmithKline
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H334
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
Physical hazards
Not classified.
Health hazards
Sensitization, respiratory Category 1 Sensitization, skin Category 1
Environmental hazards
Not classified.
Signal word
Danger
Hazard statements
H317 May cause an allergic skin reaction. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Prevention
P261 Avoid breathing dust. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear protective gloves. P284 Wear respiratory protection.
Response
P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P333 + P313 If skin irritation or rash occurs: Get medical advice/attention. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTRE/doctor/. P362 + P364 Take off contaminated clothing and wash it before reuse.
Storage
Not available.
Disposal
P501 Dispose of contents/container (in accordance with related regulations).
Other hazards which do not result in classification
This product will support combustion. May form explosible dust-air mixture if dispersed. Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
32.52 % of the mixture consists of component(s) of unknown acute oral toxicity. 32.52 % of the mixture consists of component(s) of unknown acute dermal toxicity. 95.71 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 95.71 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment. National/local information Not available
